StockWatch
·
Pesticides & Agrochemicals
Management Change25 Aug 2026, 01:45 pm

Mahamaya Lifesciences Appoints New Directors, Approves AGM

AI Summary

Mahamaya Lifesciences Ltd announced key board changes and corporate actions following a board meeting on August 25, 2026. The company approved the notice for its 24th Annual General Meeting (AGM) to be held on September 29, 2026, and the Board's Report for FY 2025-26. Significant appointments include Mr. Bhagirath Choudhary as Additional Independent Director. Dr. Gopal Krishna Raju and Dr. Charudatta Digambar Mayee were re-appointed as Independent Directors. The company also approved the re-designation of Mr. Krishnamurthy Ganesan to Chairman and Executive Non-Independent Director, and Mr. Prashant Krishnamurthy to Managing Director. Additionally, Mr. Amarendra Mohapatra was elevated to Chief Financial Officer (CFO), and Mr. Kush Mishra appointed as Company Secretary. The board also approved revisions in remuneration for key personnel.

Key Highlights

  • Mr. Bhagirath Choudhary appointed as Additional Independent Director.
  • Dr. Gopal Krishna Raju and Dr. Charudatta Digambar Mayee re-appointed as Independent Directors.
  • Key management re-designations approved, including CMD and MD roles.
  • 24th AGM scheduled for September 29, 2026; FY26 annual report approved.
  • New CFO and Company Secretary appointed.